JHS Svendgaard Laboratories Share Price

    10.85
    +0.55 (5.34%)
    JHS • 29 Aug, 2025 | 11:03 AM
    Buy

    1Y Annualised Return

    -62.43%

    3Y Annualised Return

    -22.59%

    5Y Annualised Return

    -10.08%

    10Y Annualised Return

    -2.10%

    The current prices are delayed, login or Open Demat Account for live prices.

    JHS Svendgaard Laboratories Stock Performance

    1W Return-0.55
    1Y Return-60.21
    Today's Low10.41
    Prev. Close10.30
    Mkt Cap (Cr.)88.17
    1M Return-11.93
    3Y Return-51.26
    52-Week High32.69
    Open10.98
    PE Ratio0.00
    6M Return-17.05
    Today's High10.98
    52-Week Low10.02
    Face Value10

    JHS Svendgaard Laboratories Company background

    Founded in: 2004
    Managing director: Nikhil Nanda.
    JHS Svendgaard Laboratories Limited manufactures the entire range of oral care product at its ISOcertified state oftheart manufacturing facilities at Kala Amb (Himachal Pradesh). The Company was incorporated on October 8, 2004 in Himachal Pradesh by the Registrar of Companies, Punjab, Himachal Pradesh Chandigarh situated at Jalandhar with the main object to manufacture and or trade of/in dental/oral care products, which includes toothbrushes, toothpaste, tooth powder, mouth rinse, whitening gel, effervescent tablets, tongue cleaners etc. The company was promoted by Nikhil Nanda.Initially, they manufactured only toothbrushes but realizing the vast potential of the oral care market, they ventured into manufacturing of other dental care products like toothpastes, Mouthwash, Denture tablets etc. Some of the prominent brands with whom the Company has been associated with during its journey includes Amway India Enterprises Pvt. Ltd., Dabur India Limited, Patanjali Ayurved Limited, Hindustan Unilever Limited, Me N Moms Pvt. Ltd., Vestige Marketing Pvt. Ltd., Colgate Palmolive India Ltd., Elder Health Care Limited, J. L. Morisons India Limited,Dr. Fresh Inc., Boots, Lavoris, Walgreens, Walmart and many more recognized brands.In the year 2005, the company acquired the business from the three proprietary concerns namely Sunehari Svendgaard Laboratories, Sunehari Oral Care and Jai Hanuman Exports with effect from April 1, 2005. These three proprietary concerns became the three units of the company, namely Unit I SSL, Unit II SOC and Unit III JHE.In the year 2006, Unit IIIJHE was awarded the status of Star Export House (one Star) by the Government of India effective from April 1, 2005 to March 31, 2009.During the year 200607, the company increased the production capacity of Oral Care Products by 1.50 crore Pcs to 7.00 crore Pcs. In October 21, 2006, the company shares were listed on the Bombay Stock Exchange Ltd and the National Stock Exchange of India Ltd. In April 2, 2007, the company commenced the first phase of commercial Production at Kalaamb in Himachal Pradesh. In April 10, 2007, they acquired 9400 equity shares of Rs 10 each of Nikiven Personal Care Products Pvt Ltd NIKIVEN constituting 51.08% of the paidup capital. With this acquisition, Nikiven became a subsidiary of the company.During the year 200708, the company set up a 100% subsidiary company in Ras Al Khaimah Free Trade Zone, UAE with the name of Jones H Smith, FZE. In April 2008, they set up a subsidiary company with the name JHS Svendgaard Dental Care Ltd. During the year 200809, the company increased the production capacity of Oral Care Products by 13.02 crore Pcs to 24.62 crore Pcs. In February 4, 2009, they received the Best Performing Enterprise Award Runnerup (Turnover from Rs 26 to 100 crore) at Plasticon Awards 2009 for the oral care business with a Complete Range of Oral Care Products from The Plastindia Foundation. In April 2009, the company launched their own brand Dr. Gold, to use their experience in the oral care industry and encash the market opportunities.The Scheme of Amalgamation of M/s JHS Svendgaard Hygiene Products Limited and M/s Waves Hygiene Products (a Partnership Firm) with M/s JHS Svendgaard Laboratories had been approved by the Delhi High Court on 30th August, 2011 and by the Shimla High Court on 28 May, 2012. Resultantly, all the assets and liabilities of JHS Svendgaard Laboratories Limited (Transferor Company) and M/s. Waves Hygiene Products (Transferor Firm) was transferred to Company effective from 31 March, 2010, i.e. the Appointed Date.During 201718, M/s JHS Svendgaard Retail Ventures Pvt. Ltd. became the Subsidiary of the company with effect from April 13, 2018. JHS Svendgaard Brands Limited (formerly known as JHS Svendgaard Dental Care Limited) ceased to be Subsidiary of the Company w.e.f 01st September, 2020. During 202021, the Composite Scheme of Arrangement for Demerger of Retail Investment Division (Demerged Undertaking) of JHS Svendgaard Laboratories Limited (Demerged Company) and vesting of the same with JHS Svendgaard Retail Ventures Private Limited (Resulting Company) on a going concern basis and immediately thereupon, amalgamation of JHS Svendgaard Brands Limited (Transferor Company) with JHS Svendgaard Laboratories Limited (Transferee Company) was approved on 09th October, 2020.

    JHS Svendgaard Laboratories Financial Highlights


    JHS Svendgaard Laboratories reported a Q1 FY 2025-26 revenue of ₹23.45 crore, up 26.3% YoY, with net profit increased 386.2% to ₹1.06 crore. For the full year FY2025–2026, revenue reached ₹94.87 crore and profit touched at ₹-19.74 crore.

    As of 29 Aug, 2025, JHS Svendgaard Laboratories share price is ₹10.8. The stock opened at ₹11 and had closed at ₹10.3 the previous day. During today’s trading session, JHS Svendgaard Laboratories share price moved between ₹10.41 and ₹10.98, with an average price for the day of ₹10.70. Over the last 52 weeks, the stock has recorded a low of ₹10.02 and a high of ₹32.69. In terms of performance, JHS Svendgaard Laboratories share price has declined by 20.5% over the past six months and has declined by 62.43% over the last year.
    Read More
    JHS Svendgaard Laboratories SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years
    Total Investment of ₹65,00,000
    Would have become ₹48,27,364 (-25.73%)
    Daily SIP of 25,000 would have become 48,27,364 in 1 year with a gain of -16,72,635 (-25.73%)
    View details of Market Depth

    JHS Svendgaard Laboratories Fundamental

    Market Cap (in crs)

    88.17

    Face Value

    10

    Turnover (in lacs)

    4.79

    Key Metrics

    Qtr Change %
    New 52W Low in past week
    -23.6
    Dividend yield 1yr %
    0

    JHS Svendgaard Laboratories Key Financials

    View more
    Loading chart...
    Loading chart...
    Loading chart...
    Loading chart...
    JHS Svendgaard Laboratories Quarterly Revenue
    Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    23.45 Cr
    25.17 Cr
    22.66 Cr
    19.68 Cr
    24.48 Cr
    JHS Svendgaard Laboratories Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    94.87 Cr
    75.11 Cr
    110.6 Cr
    95.64 Cr
    108.31 Cr
    152.95 Cr
    JHS Svendgaard Laboratories Quarterly Net Profit/Loss
    Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    1.06 Cr
    -6.96 Cr
    -1.84 Cr
    -10.32 Cr
    -0.63 Cr
    JHS Svendgaard Laboratories Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    -19.74 Cr
    -4.06 Cr
    -16.78 Cr
    -4.29 Cr
    1.34 Cr
    -4.86 Cr

    JHS Svendgaard Laboratories Result Highlights

    • JHS Svendgaard Laboratories Ltd reported a 6.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 1.4%.

    • Its expenses for the quarter were up by 4.2% QoQ and down 3.2% YoY.

    • The net profit decreased 241.3% QoQ and decreased 268.3% YoY.

    • The earnings per share (EPS) of JHS Svendgaard Laboratories Ltd stood at 0.1 during Q1 FY 2025-26.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    JHS Svendgaard Laboratories Shareholding Pattern

    Promoter
    34.6%
    Foreign Institutions
    1.6%
    Public
    63.9%
    Promoter
    34.6%
    Foreign Institutions
    1.6%
    Public
    63.8%
    Promoter
    34.6%
    Foreign Institutions
    1.6%
    Public
    63.8%
    Promoter
    34.6%
    Foreign Institutions
    1.7%
    Public
    63.8%
    Promoter
    37.7%
    Foreign Institutions
    0.2%
    Domestic Institutions
    6%
    Public
    56%
    Promoter
    37.7%
    Foreign Institutions
    2.3%
    Domestic Institutions
    6.2%
    Public
    53.8%

    JHS Svendgaard Laboratories Technical Analysis

    Moving Averages Analysis
    10.85
    Current Price
    Bullish Moving Averages
    2
    Bearish Moving Averages
    14
    5Day EMA
    10.60
    10Day EMA
    11.00
    12Day EMA
    11.00
    20Day EMA
    11.40
    26Day EMA
    11.60
    50Day EMA
    12.20
    100Day EMA
    13.30
    200Day EMA
    15.50
    5Day SMA
    10.70
    10Day SMA
    11.00
    20Day SMA
    11.50
    30Day SMA
    11.90
    50Day SMA
    12.40
    100Day SMA
    13.20
    150Day SMA
    13.90
    200Day SMA
    15.90
    Delivery & Volume
    Loading chart...

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    98883 Rs
    143030 Rs
    Week Rs
    87167 Rs
    139421 Rs
    Month Rs
    135457 Rs
    224312 Rs
    10.33
    Pivot
    Resistance
    First Resistance
    10.65
    Second Resistance
    10.99
    Third Resistance
    11.31
    Support
    First Support
    9.99
    Second support
    9.67
    Third Support
    9.33
    Relative Strength Index
    29.38
    Money Flow Index
    24.05
    MACD
    -0.54
    MACD Signal
    -0.45
    Average True Range
    0.72
    Average Directional Index
    22.74
    Rate of Change (21)
    -17
    Rate of Change (125)
    -27
    Name
    Holding Percent
    AEGIS INVESTMENT FUND PCC
    1.57

    JHS Svendgaard Laboratories Latest News

    28 AUG 2025 | Thursday

    JHS Svendgaard Laboratories Ltd - 532771 - Reg. 34 (1) Annual Report.

    28 AUG 2025 | Thursday

    JHS Svendgaard Laboratories Ltd - 532771 - Notice Of 21St Annual General Meeting Of The Company.

    26 AUG 2025 | Tuesday

    JHS Svendgaard Laboratories Ltd - 532771 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    View More

    JHS Svendgaard Laboratories Share Price FAQs

    JHS Svendgaard Laboratories share price is ₹10.85 in NSE and ₹10.86 in BSE as on 29/8/2025.

    JHS Svendgaard Laboratories share price in the past 1-year return was -60.21. The JHS Svendgaard Laboratories share hit a 1-year low of Rs. 10.02 and a 1-year high of Rs. 32.69.

    The market cap of JHS Svendgaard Laboratories is Rs. 88.17 Cr. as of 29/8/2025.

    The PE ratios of JHS Svendgaard Laboratories is 0 as of 29/8/2025.

    The PB ratios of JHS Svendgaard Laboratories is 0.51 as of 29/8/2025

    You can easily buy JHS Svendgaard Laboratories shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of JHS Svendgaard Laboratories share price is ₹32.69 and ₹10.02 as of 29/8/2025.

    The earnings per share (EPS) of JHS Svendgaard Laboratories stood at 0.1 during Q1 FY 2025-26.

    Please be aware that JHS Svendgaard Laboratories stock prices are subject to continuous fluctuations due to various factors.

    Open Demat Account
    +91 -

    Popular Stocks
    56.29
    -0.03 (-0.05%)
    118.98
    +0.40 (+0.34%)
    676.00
    +0.55 (+0.08%)
    2,264.50
    -10.70 (-0.47%)
    141.05
    +0.02 (+0.01%)
    306.70
    -1.95 (-0.63%)
    154.66
    +1.03 (+0.67%)
    310.85
    -4.65 (-1.47%)
    367.95
    +4.10 (+1.13%)
    373.20
    +2.10 (+0.57%)
    Top Gainers
    586.50
    +14.85 (+2.60%)
    5,351.00
    +115.50 (+2.21%)
    370.80
    +6.95 (+1.91%)
    12,722.00
    +201.00 (+1.61%)
    407.10
    +6.20 (+1.55%)
    Top Losers
    3,225.90
    -69.40 (-2.11%)
    311.80
    -3.70 (-1.17%)
    1,485.70
    -14.40 (-0.96%)
    7,667.50
    -60.50 (-0.78%)
    1,153.60
    -8.80 (-0.76%)
    Open Demat Account
    +91 -